rs35936514 — LHPP LHPP depression risk variant
Intronic/3'UTR variant in LHPP, a histidine phosphatase essential for stress resilience in the prefrontal cortex — the T allele is associated with increased risk for major depressive disorder, particularly following chronic stress
Details
- Gene
- LHPP
- Chromosome
- 10
- Risk allele
- T
- Clinical
- Risk Factor
- Evidence
- Strong
Population Frequency
Category
Mood & BehaviorSee your personal result for LHPP
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
The Prefrontal Phosphatase — When Stress Rewires the Brain
Most people associate depression with serotonin. LHPP tells a different story — one about a small enzyme in the prefrontal cortex that quietly prevents stress from reshaping your brain. When LHPP function is reduced, chronic stress finds an open door into the neural circuitry that governs mood, motivation, and resilience.
LHPP encodes phospholysine phosphohistidine inorganic pyrophosphate phosphatase11 phospholysine phosphohistidine inorganic pyrophosphate phosphatase
A HAD-family phosphatase that removes phosphate groups from histidine residues on
target proteins. Histidine phosphorylation is an understudied but functionally
important post-translational modification in mammalian cells, regulating kinase
signaling cascades. It was essentially unknown in psychiatry until the
CONVERGE consortium22 CONVERGE consortium
Collaborative Research on the Genetics of Depression in
East Asians — a large-scale genetics consortium focused on recurrent major
depressive disorder in Han Chinese women identified it in
a landmark 2015 Nature study33 a landmark 2015 Nature study
CONVERGE consortium. Sparse whole-genome
sequencing identifies two loci for major depressive disorder. Nature,
2015, sequencing 5,303 cases and
5,337 controls to find just two genome-wide significant loci — one near SIRT1 and
one in LHPP (P = 6.45 × 10⁻¹²). The rs35936514 variant sits in the 3' UTR and
flanking intronic region of LHPP on chromosome 10, likely affecting expression
levels rather than protein structure.
The Mechanism
LHPP acts as a brake on stress-induced neuronal dysfunction. In the
medial prefrontal cortex44 medial prefrontal cortex
A region of the prefrontal cortex critical for
executive function, emotional regulation, and the top-down suppression of the
stress response. It communicates extensively with the amygdala and hippocampus
to modulate fear and mood (mPFC), LHPP dephosphorylates a network of
histidine kinase substrates55 histidine kinase substrates
Proteins — including NME1/2 — that carry
phosphate groups on histidine amino acids. When these kinases are
over-active, downstream signaling cascades including MAPK and PI3K/AKT are
altered, reducing glutamatergic synaptic transmission including NME1/2.
When LHPP levels fall — whether from reduced expression due to the T allele or
from chronic stress itself suppressing LHPP — histidine phosphorylation rises
unchecked, weakening glutamatergic synaptic transmission in exactly the circuits
that should be most resilient.
Lin et al. (2023)66 Lin et al. (2023)
Lin D et al. LHPP, a risk factor for major depressive
disorder, regulates stress-induced depression-like behaviors through its
histidine phosphatase activity. Molecular Psychiatry,
2023 showed in mice that mPFC LHPP
deletion alone produced no spontaneous depression-like behavior — but on exposure
to chronic social defeat stress, LHPP-knockout mice showed dramatically augmented
behavioral deficits. Crucially, re-introducing wild-type LHPP reversed the
deficits, while a phosphatase-dead LHPP mutant did not, confirming the enzymatic
activity is required. A parallel mechanism runs through astrocytes:
Sha et al. (2023)77 Sha et al. (2023)
Sha L et al. LHPP-mediated inorganic pyrophosphate
hydrolysis-driven lysosomal acidification in astrocytes regulates adult
neurogenesis. Cell Reports,
2023 showed that LHPP normally drives
lysosomal acidification88 lysosomal acidification
Lysosomes require an acidic environment (pH ~5) to
function as the cell's recycling centers. In astrocytes, LHPP hydrolyzes
inorganic pyrophosphate to fuel this acidification. Without it, lysosomal
function is impaired, the C/EBPβ transcription factor accumulates, and
downstream chemokine signaling promoting neurogenesis is triggered in
astrocytes; in its absence, the C/EBPβ pathway triggers compensatory adult
neurogenesis that confers stress resilience. This counterintuitive finding
(less LHPP → more resilience in knockout mice) may reflect that the
full-knockout model removes a gene globally, while the rs35936514 T allele
reduces rather than abolishes LHPP expression in specific circuits.
In the ventral hippocampus, a complementary mechanism operates:
Zhuang et al. (2024)99 Zhuang et al. (2024)
Zhuang L et al. LHPP in glutamatergic neurons of
the ventral hippocampus mediates depression-like behavior by dephosphorylating
CaMKIIα and ERK. Biological Psychiatry,
2024 found that LHPP levels
increase in glutamatergic neurons during stress-induced depression, and
that knocking out LHPP in these neurons enhanced spontaneous activity and
stress resilience via the CaMKIIα/ERK pathway1010 CaMKIIα/ERK pathway
CaMKII (calcium/calmodulin-
dependent protein kinase II) and ERK (extracellular signal-regulated kinase)
regulate synaptic plasticity and BDNF expression. LHPP dephosphorylates both,
reducing their activity and impairing the BDNF/PSD95-mediated synaptic
strengthening that underlies mood resilience. Esketamine — but not
fluoxetine — reversed LHPP-induced depression-like behaviors, pointing
toward glutamatergic rather than serotonergic modulation as the relevant
therapeutic axis.
The Evidence
The CONVERGE study represents one of the cleanest GWAS findings in depression genetics. By restricting the sample to Han Chinese women with recurrent, severe MDD — reducing phenotypic and genetic heterogeneity — the consortium achieved genome-wide significance with just 10,640 individuals, far fewer than most psychiatric GWAS require. The LHPP signal (P = 6.45 × 10⁻¹²) was validated in an independent replication cohort. rs35936514 sits in intron 2 of LHPP and the flanking 3' UTR, and the T allele is associated with reduced LHPP expression in the prefrontal cortex.
At the neural circuit level, Cui et al. (2020)1111 Cui et al. (2020)
Cui L et al. Association of
LHPP genetic variation (rs35936514) with structural and functional connectivity
of hippocampal-corticolimbic neural circuitry. Brain Imaging and Behavior,
2020 examined 122 healthy
participants and found that T-allele carriers showed increased hippocampal
connectivity to the rostral anterior cingulate cortex and higher fractional
anisotropy in the fornix — structural and functional signatures consistent
with altered top-down emotional regulation. These brain connectivity differences
were present without clinical depression, suggesting the risk phenotype is
a continuous trait rather than a categorical diagnosis.
Earlier family-based work by
Neff et al. (2009)1212 Neff et al. (2009)
Neff CD et al. Evidence for HTR1A and LHPP as interacting
genetic risk factors in major depression. Molecular Psychiatry,
2009 found a chromosome 10 linkage
peak (HLOD = 4.4) in Utah pedigrees with familial depression and identified
disease-segregating LHPP SNPs in the linkage region. The LHPP effects in that
study were contingent on HTR1A genotype, hinting at an interaction between
serotonin receptor sensitivity and LHPP-mediated stress signaling.
Practical Implications
The LHPP mechanism converges on a clear biological theme: glutamatergic synaptic function under stress. T-allele carriers do not appear to have impaired mood at baseline — the risk emerges under chronic stress. This has direct implications for how carriers should think about their mental health strategy: minimizing the duration and intensity of chronic stressors matters more than managing acute stress reactions.
The esketamine finding from Zhuang et al. is clinically relevant: if depression does develop in T-allele carriers, the evidence points toward glutamate-targeting treatments (esketamine/ketamine) having particular mechanistic relevance versus standard SSRIs, which do not directly address the LHPP-CaMKII/ERK pathway.
Interactions
The Neff et al. (2009) data suggest a potential interaction between LHPP (rs35936514) and the HTR1A serotonin receptor gene. In that family-based study, the LHPP depression association was modulated by HTR1A genotype, suggesting that individuals carrying risk variants in both genes may have compounded vulnerability. The mechanistic intersection — serotonergic regulation of prefrontal excitatory tone — offers a plausible biological substrate.
The BDNF Val66Met variant (rs6265) is also relevant: since LHPP deficiency reduces CaMKII/ERK activity and thereby impairs BDNF/PSD95-mediated synaptic strengthening, T-allele carriers who also carry the BDNF Met allele (reduced activity-dependent BDNF secretion) may experience compounded vulnerability to stress-induced synaptic weakening in prefrontal and hippocampal circuits.
Genotype Interpretations
What each possible genotype means for this variant:
Common LHPP genotype — normal prefrontal stress resilience
The C/C genotype at rs35936514 is associated with normal LHPP expression in the medial prefrontal cortex and ventral hippocampus. LHPP at normal levels maintains controlled histidine phosphorylation of target proteins (including NME1/2), preserving glutamatergic synaptic transmission during stress. Astrocytic lysosomal acidification proceeds normally, supporting baseline adult neurogenesis. The CONVERGE GWAS and subsequent mechanistic studies consistently identify the T allele as the risk-associated variant; the C allele represents the ancestral, non-risk state at this locus.
One copy of the depression risk allele — moderately increased vulnerability under chronic stress
Heterozygous CT carriers have one copy of the T allele, which reduces LHPP expression relative to CC homozygotes. This partial reduction in LHPP activity likely produces an intermediate phenotype: glutamatergic transmission and prefrontal-hippocampal connectivity are altered (as shown by Cui et al. 2020 in healthy T-allele carriers), but the clinical depression risk emerges primarily when the reduced enzymatic capacity is overwhelmed by chronic stress. The CaMKII/ERK pathway shows intermediate dephosphorylation efficiency, and BDNF/PSD95 expression at synapses may be marginally reduced under stress loads. The T allele frequency in East Asian populations is approximately 27-32%, meaning this genotype is considerably more common in those ancestries (projected CT + TT frequency: ~45-55% vs ~13% in Europeans).
Two copies of the LHPP depression risk allele — substantially elevated vulnerability under chronic stress
TT homozygotes at rs35936514 carry the greatest reduction in LHPP expression. Both copies of the gene's regulatory region carry the T allele, leading to the most impaired histidine phosphatase activity in the mPFC and ventral hippocampus under stress conditions. The CaMKIIα and ERK pathways remain over-phosphorylated during stress, impairing BDNF and PSD95 expression and weakening glutamatergic synaptic strength in circuits critical to mood regulation.
The brain imaging data from Cui et al. (2020) showed that T-allele carriers already exhibit altered hippocampal-rACC connectivity at rest, even without clinical depression — suggesting the neural signature of vulnerability is present before any mood episode. In terms of treatment, the Zhuang et al. (2024) Biological Psychiatry findings are directly relevant: esketamine (an NMDA receptor antagonist acting on the glutamate system) reversed LHPP-mediated depression-like behaviors in preclinical models, while fluoxetine (SSRI) did not. This mechanistic specificity may translate to better treatment outcomes with glutamate-targeting interventions if depression develops.
The T allele also carries a human mutation-level implication: human LHPP mutations E56K and S57L (identified in Zhuang et al. 2024) heightened CaMKII/ERK pathway signaling, confirming that even partial loss of LHPP function through natural variation is biologically meaningful.